Cartesian Therapeutics, Inc.RNACNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank73
3Y CAGR-1.7%
5Y CAGR+4.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-1.7%/yr
vs +9.7%/yr prior
5Y CAGR
+4.0%/yr
Recent deceleration
Acceleration
-11.4pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $89.50M | +8.1% |
| 2024 | $82.81M | -26.3% |
| 2023 | $112.42M | +19.3% |
| 2022 | $94.20M | +5.0% |
| 2021 | $89.67M | +22.1% |
| 2020 | $73.42M | +24.2% |
| 2019 | $59.13M | -9.0% |
| 2018 | $64.95M | +2.7% |
| 2017 | $63.24M | +50.7% |
| 2016 | $41.95M | - |